Skip to content

Clinical trials

Completed Hemorrhage trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Status: Completed Country / region: China Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20071
20081
20091
20102
20111
20133
20146
20151
20162
20174
20183
20192
20202
20211
20221
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese Academy of Medical Sciences, Fuwai Hospital2
Chinese University of Hong Kong2
Mayo Clinic2
Peking Union Medical College Hospital2
Shanghai Jiao Tong University School of Medicine2
Xijing Hospital2
AstraZeneca1
Beijing Chao Yang Hospital1
Beijing Tiantan Hospital1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage37
Cerebral Hemorrhage2
Cerebrovascular Disorders2
Critical Illness2
Intracranial Hemorrhages2
Liver Cirrhosis2
Peptic Ulcer2
Respiratory Insufficiency2
Sepsis2
Shock2

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.